Related Experiment Video
Updated: Jan 25, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Aberrant localization of signaling proteins in skin cancer: Implications for treatment
Thomas R Holmes1, Shravya Dindu1, Laura A Hansen1
1Department of Biomedical Sciences, Creighton University, Omaha, Nebraska.
Abstract:
Aberrant subcellular localization of signaling proteins can provide cancer cells with advantages such as resistance to apoptotic cell death, increased invasiveness and more rapid proliferation. Nuclear to cytoplasmic shifts in tumor-promoting proteins can lead to worse patient outcomes, providing opportunities to target cancer-specific processes. Herein, we review the significance of dysregulated protein localization with a focus on skin cancer. Altered localization of signaling proteins controlling cell cycle progression or cell death is a common feature of cancer. In some instances, aberrant subcellular localization results in an acquired prosurvival function. Taking advantage of this knowledge reveals novel targets useful in the development of cancer therapeutics.
Insights
Aberrant protein localization in cancer cells, particularly skin cancer, can drive tumor growth and resistance to therapy. Understanding these shifts offers new therapeutic targets for improved patient outcomes.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Aberrant subcellular localization of signaling proteins confers cancer cell advantages like apoptosis resistance, invasiveness, and proliferation.
- Nuclear to cytoplasmic shifts in tumor-promoting proteins correlate with poorer patient outcomes.
- Dysregulated protein localization is a common hallmark of cancer, impacting key cellular processes.
Purpose of the Study:
- To review the significance of dysregulated protein localization in cancer.
- To focus on the role of altered protein localization in skin cancer.
- To highlight the potential of targeting aberrant localization for cancer therapeutics.
Main Methods:
- Literature review of studies on protein localization and cancer.
- Analysis of signaling pathways affected by protein mislocalization.
- Examination of therapeutic strategies targeting protein localization.
Main Results:
- Altered localization of cell cycle and cell death regulators is frequent in cancer.
- Aberrant localization can result in acquired prosurvival functions for cancer cells.
- Specific protein localization shifts are critical in skin cancer progression.
Conclusions:
- Dysregulated protein localization is a critical factor in cancer development and progression.
- Targeting aberrant subcellular protein localization presents a promising therapeutic avenue.
- Further research into protein localization mechanisms can yield novel anti-cancer drugs.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Nuclear Localization Signals and Import
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Paracrine Signaling
Yeast Signaling

